Federal Circuit says Novartis invention is unpatentable

13-04-2017

Federal Circuit says Novartis invention is unpatentable

photogearch / iStockphoto.com

The US Court of Appeals for the Federal Circuit has affirmed a ruling of the Patent Trial and Appeal Board (PTAB) that a patent belonging to Novartis and Mitsubishi Pharma is obvious.


US Court of Appeals for the Federal Circuit, patent, PTAB, USPTO, Novartis, Mylan, Apotex, IPR, inter partes review, unpatentable

LSIPR